Hyoscyamine Sulfate Tablet
Product Images NDC 0615-8537

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hyoscyamine Sulfate (NDC 0615-8537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Hyoscyamine 8537 1)

Structure (Hyoscyamine 8537 1)
Chemical structure diagram of Hyoscyamine Sulfate, illustrating the molecular components including methyl groups, hydroxyl, phenyl, and sulfate groups, together with hydrate molecules.*
FDA Label Image

Ani-logo (Hyoscyamine 8537 2)

FDA Label Image

Principal Display Panel (Hyoscyamine 8537 3)

Principal Display Panel (Hyoscyamine 8537 3)
Hyoscyamine Sulfate Tablets USP 0.125 mg oral tablets packaging label displaying the product name, dosage strength, and quantity of 30 tablets. Label shows NCS HealthCare of KY, LLC dba Vangard Labs as the labeler and ANI Pharmaceuticals as manufacturer. Includes barcodes, lot number 8537, storage instructions, and institutional use indication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.